Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-19 4:34 pm Purchase | 2022-08-17 | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 9,192,814 19.990% | 5,732,463 (+165.66%) | Filing History |
| 2022-08-12 12:35 pm Sale | 2022-08-02 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Frazier Life Sciences Public Fund, L.P. | 300,000 1.100% | -1,205,200 (-80.07%) | Filing History |
| 2022-05-31 4:40 pm Purchase | 2022-05-26 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Millennium Management LLC | 1,422,477 5.100% | 1,422,477 (New Position) | Filing History |
| 2022-05-19 4:30 pm Purchase | 2022-05-09 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Commodore Capital LP | 1,371,339 5.000% | 1,371,339 (New Position) | Filing History |
| 2022-02-14 4:32 pm Purchase | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Point72 Asset Management, L.P. | 472,864 2.200% | 46,702 (+10.96%) | Filing History |
| 2022-02-14 4:19 pm Purchase | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Healthcare Capital Partners III L.P. | 2,205,268 9.990% | 262,213 (+13.49%) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | RA Capital Management, L.P. | 0 0.000% | -388,385 (Position Closed) | Filing History |
| 2022-02-14 4:05 pm Purchase | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | D. E. Shaw & Co., L.P. | 764,613 3.500% | 44,240 (+6.14%) | Filing History |
| 2022-02-14 3:04 pm Purchase | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Cormorant Asset Management LP | 1,436,322 6.280% | 977,178 (+212.83%) | Filing History |
| 2022-02-14 2:47 pm Sale | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Logos Global Management LP | 0 0.000% | -1,495,000 (Position Closed) | Filing History |
| 2022-02-14 1:51 pm Sale | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | BIOTECHNOLOGY VALUE FUND L P | 2,202,315 9.990% | -5,381,904 (-70.96%) | Filing History |
| 2022-02-14 06:19 am Purchase | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Citadel Advisors LLC | 943,340 4.300% | 516,122 (+120.81%) | Filing History |
| 2022-02-14 06:12 am Purchase | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm Biocapital Advisors LP | 1,209,051 5.570% | 1,209,051 (New Position) | Filing History |
| 2022-02-11 4:19 pm Sale | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Ally Bridge MedAlpha Master Fund L.P. | 604,774 2.800% | -325,205 (-34.97%) | Filing History |
| 2022-02-04 08:01 am Sale | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Hawkes Bay Master Investors (Cayman) L.P. | 0 0.000% | -363,284 (Position Closed) | Filing History |
| 2022-01-28 1:39 pm Purchase | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Frazier Life Sciences Public Fund, L.P. | 1,505,200 6.900% | 200,000 (+15.32%) | Filing History |
| 2021-10-27 6:12 pm Purchase | 2021-10-21 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Avidity Partners Management LP | 1,120,925 6.600% | 1,120,925 (New Position) | Filing History |
| 2021-10-14 4:05 pm Purchase | 2021-10-04 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Healthcare Capital Partners III L.P. | 1,943,055 9.990% | 1,943,055 (New Position) | Filing History |
| 2021-10-08 08:36 am Sale | 2021-09-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | -578,560 (Position Closed) | Filing History |
| 2021-09-30 4:30 pm Purchase | 2021-09-21 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Vivo Opportunity LLC | 1,300,000 7.700% | 1,300,000 (New Position) | Filing History |